86 related articles for article (PubMed ID: 17499215)
1. Wp specific methylation of highly proliferated LCLs.
Park JH; Jeon JP; Shim SM; Nam HY; Kim JW; Han BG; Lee S
Biochem Biophys Res Commun; 2007 Jun; 358(2):513-20. PubMed ID: 17499215
[TBL] [Abstract][Full Text] [Related]
2. Latency pattern of Epstein-Barr virus and methylation status in Epstein-Barr virus-associated hemophagocytic syndrome.
Yoshioka M; Kikuta H; Ishiguro N; Endo R; Kobayashi K
J Med Virol; 2003 Jul; 70(3):410-9. PubMed ID: 12767005
[TBL] [Abstract][Full Text] [Related]
3. Methylation status of the Epstein-Barr virus (EBV) BamHI W latent cycle promoter and promoter activity: analysis with novel EBV-positive Burkitt and lymphoblastoid cell lines.
Hutchings IA; Tierney RJ; Kelly GL; Stylianou J; Rickinson AB; Bell AI
J Virol; 2006 Nov; 80(21):10700-11. PubMed ID: 16920819
[TBL] [Abstract][Full Text] [Related]
4. Variable methylation of the Epstein-Barr virus Wp EBNA gene promoter in B-lymphoblastoid cell lines.
Elliott J; Goodhew EB; Krug LT; Shakhnovsky N; Yoo L; Speck SH
J Virol; 2004 Dec; 78(24):14062-5. PubMed ID: 15564516
[TBL] [Abstract][Full Text] [Related]
5. Methylation of transcription factor binding sites in the Epstein-Barr virus latent cycle promoter Wp coincides with promoter down-regulation during virus-induced B-cell transformation.
Tierney RJ; Kirby HE; Nagra JK; Desmond J; Bell AI; Rickinson AB
J Virol; 2000 Nov; 74(22):10468-79. PubMed ID: 11044091
[TBL] [Abstract][Full Text] [Related]
6. Cell phenotype-dependent splicing reflecting differential promoter usage for EBNA transcripts in EBV-carrying cells.
Hu LF; Chen F; Altiok E; Winberg G; Klein G; Ernberg I
Gan To Kagaku Ryoho; 2000 May; 27 Suppl 2():248-60. PubMed ID: 10895161
[TBL] [Abstract][Full Text] [Related]
7. EBV transformation and cell culturing destabilizes DNA methylation in human lymphoblastoid cell lines.
Grafodatskaya D; Choufani S; Ferreira JC; Butcher DT; Lou Y; Zhao C; Scherer SW; Weksberg R
Genomics; 2010 Feb; 95(2):73-83. PubMed ID: 20005943
[TBL] [Abstract][Full Text] [Related]
8. Epigenetic regulation of latent Epstein-Barr virus promoters.
Takacs M; Banati F; Koroknai A; Segesdi J; Salamon D; Wolf H; Niller HH; Minarovits J
Biochim Biophys Acta; 2010; 1799(3-4):228-35. PubMed ID: 19853674
[TBL] [Abstract][Full Text] [Related]
9. Frequent methylation of p16INK4A/p14ARF promoters in tumorigenesis of Epstein-Barr virus transformed lymphoblastoid cell lines.
Nagy E; Veress G; Szarka K; Csoma E; Beck Z
Anticancer Res; 2005; 25(3B):2153-60. PubMed ID: 16158958
[TBL] [Abstract][Full Text] [Related]
10. Host cell-dependent expression of latent Epstein-Barr virus genomes: regulation by DNA methylation.
Li H; Minarovits J
Adv Cancer Res; 2003; 89():133-56. PubMed ID: 14587872
[TBL] [Abstract][Full Text] [Related]
11. An origin of DNA replication (oriP) in highly methylated episomal Epstein-Barr virus DNA localizes to a 4.5-kb unmethylated region.
Falk K; Ernberg I
Virology; 1993 Aug; 195(2):608-15. PubMed ID: 8393238
[TBL] [Abstract][Full Text] [Related]
12. Regulation and dysregulation of Epstein-Barr virus latency: implications for the development of autoimmune diseases.
Niller HH; Wolf H; Minarovits J
Autoimmunity; 2008 May; 41(4):298-328. PubMed ID: 18432410
[TBL] [Abstract][Full Text] [Related]
13. Epigenetics of latent Epstein-Barr virus genomes: high resolution methylation analysis of the bidirectional promoter region of latent membrane protein 1 and 2B genes.
Takacs M; Salamon D; Myöhänen S; Li H; Segesdi J; Ujvari D; Uhlig J; Niller HH; Wolf H; Berencsi G; Minarovits J
Biol Chem; 2001 Apr; 382(4):699-705. PubMed ID: 11405234
[TBL] [Abstract][Full Text] [Related]
14. Epigenetic dysregulation of the host cell genome in Epstein-Barr virus-associated neoplasia.
Niller HH; Wolf H; Minarovits J
Semin Cancer Biol; 2009 Jun; 19(3):158-64. PubMed ID: 19429479
[TBL] [Abstract][Full Text] [Related]
15. Down-regulation of DLX3 expression in MLL-AF4 childhood lymphoblastic leukemias is mediated by promoter region hypermethylation.
Campo Dell'Orto M; Banelli B; Giarin E; Accordi B; Trentin L; Romani M; te Kronnie G; Basso G
Oncol Rep; 2007 Aug; 18(2):417-23. PubMed ID: 17611665
[TBL] [Abstract][Full Text] [Related]
16. High-resolution analysis of CpG methylation and in vivo protein-DNA interactions at the alternative Epstein-Barr virus latency promoters Qp and Cp in the nasopharyngeal carcinoma cell line C666-1.
Bakos A; Banati F; Koroknai A; Takacs M; Salamon D; Minarovits-Kormuta S; Schwarzmann F; Wolf H; Niller HH; Minarovits J
Virus Genes; 2007 Oct; 35(2):195-202. PubMed ID: 17510783
[TBL] [Abstract][Full Text] [Related]
17. EBV transformation overrides gene expression patterns of B cell differentiation stages.
Siemer D; Kurth J; Lang S; Lehnerdt G; Stanelle J; Küppers R
Mol Immunol; 2008 Jun; 45(11):3133-41. PubMed ID: 18430472
[TBL] [Abstract][Full Text] [Related]
18. Protein-DNA interaction and CpG methylation at rep*/vIL-10p of latent Epstein-Barr virus genomes in lymphoid cell lines.
Niller HH; Salamon D; Takacs M; Uhlig J; Wolf H; Minarovits J
Biol Chem; 2001 Oct; 382(10):1411-9. PubMed ID: 11727824
[TBL] [Abstract][Full Text] [Related]
19. The Epstein-Barr virus major latent promoter Qp is constitutively active, hypomethylated, and methylation sensitive.
Tao Q; Robertson KD; Manns A; Hildesheim A; Ambinder RF
J Virol; 1998 Sep; 72(9):7075-83. PubMed ID: 9696800
[TBL] [Abstract][Full Text] [Related]
20. Steps involved in immortalization and tumorigenesis in human B-lymphoblastoid cell lines transformed by Epstein-Barr virus.
Sugimoto M; Tahara H; Ide T; Furuichi Y
Cancer Res; 2004 May; 64(10):3361-4. PubMed ID: 15150084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
